Zobair Younossi, MD
Articles
July 12th 2019
Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017
Naoky Tsai, MD Bruce Bacon, MD Michael Curry, MD Steven L. Flamm, MD Scott Milligan, PhD Nicole Wick, AS Zobair Younossi, MD Nezam Afdhal, MD
From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.
February 16th 2017
Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact
Zobair Younossi, MD Stuart C. Gordon, MD Aijaz Ahmed, MD Douglas Dieterich, MD Sammy Saab, MD Rachel Beckerman, PhD
Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 12th 2024 | Updated: December 18th 2024
Remote Test Reliably Assesses Cognitive Function in MS
